Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) SIG Poster Highlight

Nov 07 2025
Convention Center: Science in the Park - Site A - Level 3
12:45 PM - 1:15 PM

World Class Speakers

Ludovic Saba, MD, MSc
Presenter

Ludovic Saba, MD, MSc

UT Southwestern Medical Center
Nikhil Kalita, MPH
Presenter

Nikhil Kalita, MPH

UCSD MASLD Research Center
Carolin Lackner, MD
Presenter

Carolin Lackner, MD

Medical University of Graz, Austria
Pinelopi Manousou, Medical degree
Moderator

Pinelopi Manousou, Medical degree

Imperial College Healthcare NHS Trust
Rashmee Patil, MD
Moderator

Rashmee Patil, MD

Pinnacle Clinical Research

Description

Join us for a poster highlight of the top abstracts from the MASLD SIG. 
 

Journey Maps

Presentations

12:45 PM - 12:48 PM
Jun 24 2026
Convention Center - Science in the Park - Site A - Level 3

Welcome & Introductions

Pinelopi Manousou, Medical degree , Moderator
MASLD
12:48 PM - 12:53 PM
Jun 24 2026
Convention Center - Science in the Park - Site A - Level 3

Empagliflozin Reduces Incident Cirrhosis, Hepatic Decompensation, and Mortality in MASLD/MASH Patients with Diabetes: A Propensity-Matched Analysis of A Multi-institutional EHR Database

Ludovic Saba, MD, MSc , Presenter
MASLD
12:53 PM - 12:58 PM
Jun 24 2026
Convention Center - Science in the Park - Site A - Level 3

Validation of New Clinical Obesity Criteria for Steatotic Liver Disease in the United States

Nikhil Kalita, MPH , Presenter
MASLD
12:58 PM - 1:03 PM
Jun 24 2026
Convention Center - Science in the Park - Site A - Level 3

Comparison of digital images versus glass slides for the histopathological evaluation of liver biopsy samples according to the NASH-CRN scoring system for MASH: A validation performed as part of the NATiV3 study

Carolin Lackner, MD , Presenter
MASLD
1:03 PM - 1:15 PM
Jun 24 2026
Convention Center - Science in the Park - Site A - Level 3

Q&A/Panel Discussion/Closing

Rashmee Patil, MD , Moderator
MASLD